SUMMIT, N.J., July 24, 2026 — Tylenol®, the #1 doctor‑recommended pain relief brand, today announced that the U.S. Food and Drug Administration (FDA) has approved Tylenol® with Naproxen—the first and only over‑the‑counter...
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | FDA approves first OTC combo of Tylenol and Naproxen for 'non-opioid' pain relief | 0 | 10.33 | 29-07-2026 |
| 2 | FDA approves first OTC combo of Tylenol and Naproxen for 'non-opioid' pain relief | 0 | 10.33 | 01-08-2026 |
| 3 | FDA Approves Mucinex 12HR Cold & Fever Multi-Symptom (dextromethorphan, guaifenesin and naproxen) for Cold & Flu Symptoms | 0 | 14.32 | 05-08-2026 |
| 4 | FDA Approves Orzeyful (oveporexton) to Treat the Underlying Cause of Narcolepsy Type 1 | 0 | 19.75 | 05-08-2026 |
| 5 | FDA Approves Simtriyo (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) | 0 | 12.21 | 24-07-2026 |
| 6 | FDA Approves Pasatru (garetosmab-grts) for the Treatment of Fibrodysplasia Ossificans Progressiva | 0 | 15.91 | 19-08-2026 |
| 7 | FDA Approves First Orexin-Targeting Drug for Narcolepsy Type 1 | 0 | 18.04 | 05-08-2026 |
| 8 | FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients | 5 | 7 | 16-07-2026 |
| 9 | FDA approves first mRNA flu vaccine | 0 | 5.78 | 06-08-2026 |